Abstract:Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and different viral serotypes, promoters and transduction pathways can influence the targeting of AAV to different types of cells and the expression levels of numerous exogenous genes. To determine the transduction and expression patterns of AAV with different serotypes or promoters in hair cells and supporting cells in the neonatal mouse cochlea, we examined the expression of enhanced green fluorescent protein (eGFP) for five different types of AAV vectors [serotypes 2, 9, and Anc80L65 with promoter cytomegalovirus (CMV)-beta-Globin and serotypes 2 and 9 with promoter chicken beta-actin (CBA)] in in vitro cochlear explant cultures and we tested the transduction of AAV2/2-CBA, AAV2/9-CBA, and AAV2/Anc80L65-CMV by in vivo microinjection into the scala media of the cochlea. We found that each AAV vector had its own transduction and expression characteristics in hair cells and supporting cells in different regions of the cochlea. There was a tonotopic gradient for the in vitro transduction of AAV2/2-CBA, AAV2/9-CBA, AAV2/2-CMV, and AAV2/9-CMV in outer hair cells (OHCs), with more OHCs expressing eGFP at the base of the cochlea than at the apex. AAV2/2-CBA in vitro and AAV2/Anc80L65-CMV in vivo induced more supporting cells expressing eGFP at the apex than in the base. We found that AAV vectors with different promoters had different expression efficacies in hair cells and supporting cells of the auditory epithelium. The CMV-beta-Globin promoter could drive the expression of the delivered construct more efficiently in hair cells, while the CBA promoter was more efficient in supporting cells. The in vitro and in vivo experiments both demonstrated that AAV2/Anc80L65-CMV was a very promising vector for gene therapy of deafness because of its high transduction rates in hair cells. These results might be useful for selecting the appropriate vectors for gene delivery into different types of inner ear cells and thus improving the effectiveness of gene therapy.

[Recombinate Adeno-Associated Virus Raav-Nt4-adnf-9 Transfects to the Cultured Cochleae of Rats in Vitro].

[Experimental Study on Embryonic Neural Stem Cells Transplantation into Natural Rat Cochlea Via Round Window].

A study of a postauricular approach to rat cochlear scala media lateral wall for microinject lentivirus with EGFP

Adeno-Associated Viral Vector-Mediated Expression of Nt4-Adnf-9 Fusion Gene Protects Against Aminoglycoside-Induced Auditory Hair Cell Loss in Vitro

The construction and production of NT4-GFP-Ant recombinant adeno-associated virus

Treatment of adeno-associated virus mediated ADNF-9 gene transfection on guinea pig cochlea deafened by kanamycin

Construction of a gengeral adeno-associated virus vector and GFP expression in rat NIH3T3 transduced by the rAAV vector

Specific and Efficient Transduction of Cochlear Inner Hair Cells with Recombinant Adeno-Associated Virus Type 3 Vector

Comparison of gene transfer into newborn rat cochlear marginal cells in primary culture using different vectors

Transduction of Adeno-Associated Virus Vectors Targeting Hair Cells and Supporting Cells in the Neonatal Mouse Cochlea

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Therapeutic Effect of Adeno-Associated Virus (Aav)-Mediated Adnf-9 Expression on Cochlea of Kanamycin-Deafened Guinea Pigs

Construction of Prokaryotic Expression Vector for Pbv220/nt4–adnf–9

Efficient Cochlear Gene Transfection in Guinea-Pigs with Adeno-Associated Viral Vectors by Partial Digestion of Round Window Membrane

Construction and Identification of Replication-deficient Recombinant Adenovirus Cloned with a SD Rat BDNF Gene

Construction and identification of a recombinant adenovirus vector expressing rat achaete-scute homology 1

Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles

Distributional Comparison of Different AAV Vectors after Unilateral Cochlear Administration

Construction of Recombinant Plasmid Raav_2-Ires-egfp/mnsod and Its Expression in Vivo and in Vitro

Establishment of an AAV Reverse Infection-Based Array

AAV-ie Enables Safe and Efficient Gene Transfer to Inner Ear Cells.